🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
2.970
0.00 (0.00%)
Nov 19, 2026, 4:00 PM EST - Market closed

Sionna Therapeutics Stock Forecast

SION's stock price has decreased by -92.41% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 12 analysts polled by S&P Global, Sionna Therapeutics stock has a consensus rating of "Hold" and an average price target of $21. The average 1-year stock price forecast is 607.07% higher than the current stock price, while the lowest is $5.00 (+68.35%) and the highest is $63 (+2,021.21%).

Price Target: $21 (+607.07%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$21$6.00$63
Change+68.35%+607.07%+102.02%+2021.2%

Analyst Ratings

The average analyst rating for Sionna Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy881222
Buy110000
Hold1110101010
Sell110000
Strong Sell000000
Total111111121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aNov 11, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 11, 2026
RBC Capital
RBC Capital
Hold
Maintains
$5
HoldMaintains$5+68.35%Nov 10, 2026
LifeSci Capital
LifeSci Capital
Hold
Maintains
$6
HoldMaintains$6+102.02%Sep 19, 2026
Guggenheim
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aSep 16, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.62
from -1.88
EPS Next Year
-2.29
from -2.62
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-----
Operating Income
-41.37M-50.33M-70.56M-88.98M-127.66M
Net Income
-40.24M-47.26M-61.69M-75.27M-117.27M
EPS
----1.88-2.62
Free Cash Flow
----66.67M-133.89M
No. Analysts
----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-2.52
Avg-2.62
Low-2.71

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-